Survival benefit of high-dose therapy in poor-risk aggressive non-Hodgkin's lymphoma: concerns about omissions in the data presented.
Kennedy
R D
RD
Cuthbert
R G
RG
Kettle
P J
PJ
Morris
T C
TC
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use*; D016026:Bone Marrow Transplantation; D004305:Dose-Response Relationship, Drug; D006801:Humans; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy* / Q000473:pathology; D011379:Prognosis; D015203:Reproducibility of Results; D012107:Research Design; D012307:Risk Factors; D016019:Survival Analysis